The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review.

MLA

Levinta, Anastasia, et al. “The Association between Stage of Treatment-Resistant Depression and Clinical Utility of Ketamine/Esketamine: A Systematic Review.” Journal of Affective Disorders, vol. 318, Dec. 2022, pp. 139–49. EBSCOhost, https://doi.org/10.1016/j.jad.2022.08.050.

APA

Levinta, A., Meshkat, S., McIntyre, R. S., Ho, C., Lui, L. M. W., Lee, Y., Mansur, R. B., Teopiz, K. M., Rodrigues, N. B., Di Vincenzo, J. D., Ceban, F., & Rosenblat, J. D. (2022). The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review. Journal of Affective Disorders, 318, 139–149. https://doi.org/10.1016/j.jad.2022.08.050

Chicago

Levinta, Anastasia, Shakila Meshkat, Roger S McIntyre, Cameron Ho, Leanna M W Lui, Yena Lee, Rodrigo B Mansur, et al. 2022. “The Association between Stage of Treatment-Resistant Depression and Clinical Utility of Ketamine/Esketamine: A Systematic Review.” Journal of Affective Disorders 318 (December): 139–49. doi:10.1016/j.jad.2022.08.050.